Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : Vcyt save search
Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -1.41%
bladder
New Data Presented at the 2023 ATA Annual Meeting Demonstrate that Veracyte’s Afirma-Based Testing Can Uncover Key Molecular Hallmarks of Thyroid Cancer
Published: 2023-09-28 (Crawled : 23:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.39%
H: 2.27%
C: -0.17%
cancer thyroid meeting molecular
Veracyte Announces Multiple Studies Reinforcing the Value of Decipher Prostate Testing Will Be Presented at ASTRO 2023
Published: 2023-09-28 (Crawled : 15:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.39%
H: 2.27%
C: -0.17%
Veracyte to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-08-29 (Crawled : 14:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.64%
H: 0.0%
C: 0.0%
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -0.76%
H: 6.52%
C: 5.79%
conference global
New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment
Published: 2023-02-13 (Crawled : 00:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.12%
H: 4.06%
C: 3.08%
treatment asco cancer prostate cancer
Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year
Published: 2022-06-27 (Crawled : 15:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -0.88%
H: 0.89%
C: -6.88%
year
Veracyte Announces that Data for Its Genomic and Immuno-Oncology Offerings Will Be Highlighted at the 2022 ASCO Annual Meeting
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -7.46%
H: 17.4%
C: 9.87%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.22%
H: 6.51%
C: 1.66%
genomic asco
Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
Published: 2022-01-31 (Crawled : 14:30) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.74%
H: 11.95%
C: 11.47%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.53%
H: 6.93%
C: 6.86%
symposium asco cancer
Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 6.56%
H: 0.0%
C: 0.0%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
Published: 2021-10-14 (Crawled : 13:15) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 2.14%
H: 3.75%
C: 0.69%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 1.88%
H: 1.28%
C: -1.07%
genomic
Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
Published: 2021-05-14 (Crawled : 20:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 2.33%
H: 4.11%
C: 1.5%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 2.62%
H: 1.97%
C: -0.78%
treatment lung cancer genomic cancer diagnostic
Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 1.12%
H: 0.47%
C: -4.43%
genomic diagnostics diagnostic
Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
Published: 2021-04-19 (Crawled : 16:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: -2.35%
H: 2.21%
C: -3.68%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -1.88%
H: 3.31%
C: -0.42%
conference
Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020
Published: 2020-12-03 (Crawled : 21:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.84%
H: 3.33%
C: 0.65%
cancer lung cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.